240 related articles for article (PubMed ID: 23802863)
1. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
[TBL] [Abstract][Full Text] [Related]
3. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
[TBL] [Abstract][Full Text] [Related]
4. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
[TBL] [Abstract][Full Text] [Related]
5. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.
Klein S; Fabbrini E; Patterson BW; Polonsky KS; Schiavon CA; Correa JL; Salles JE; Wajchenberg BL; Cohen R
Obesity (Silver Spring); 2012 Jun; 20(6):1266-72. PubMed ID: 22262157
[TBL] [Abstract][Full Text] [Related]
6. EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.
Obermayer A; Tripolt NJ; Aziz F; Högenauer C; Aberer F; Schreiber F; Eherer A; Sourij C; Stadlbauer V; Svehlikova E; Brunner M; Goswami N; Kojzar H; Pferschy PN; Pieber TR; Sourij H
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919949
[TBL] [Abstract][Full Text] [Related]
7. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients.
Deutsch L; Ben Haim L; Sofer Y; Gluck N; Santo E; Fishman S
Surg Obes Relat Dis; 2018 Oct; 14(10):1561-1569. PubMed ID: 30449512
[TBL] [Abstract][Full Text] [Related]
9. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
[TBL] [Abstract][Full Text] [Related]
11. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
Rubino F; Marescaux J
Ann Surg; 2004 Jan; 239(1):1-11. PubMed ID: 14685093
[TBL] [Abstract][Full Text] [Related]
12. Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).
Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
Obes Surg; 2018 Aug; 28(8):2187-2196. PubMed ID: 29504053
[TBL] [Abstract][Full Text] [Related]
13. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
[TBL] [Abstract][Full Text] [Related]
15. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
Jirapinyo P; Haas AV; Thompson CC
Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
[TBL] [Abstract][Full Text] [Related]
17. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
18. The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
Rohde U; Federspiel CA; Vilmann P; Langholz E; Friis SU; Krakauer M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2017 Feb; 19(2):189-199. PubMed ID: 27696668
[TBL] [Abstract][Full Text] [Related]
19. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
[TBL] [Abstract][Full Text] [Related]
20. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model.
Paszkiewicz RL; Burch MA; Asare Bediako I; Mkrtchyan H; Piccinini F; Ader M; Bresee C; Bergman RN
Surg Obes Relat Dis; 2022 Jun; 18(6):694-702. PubMed ID: 35361540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
